» Articles » PMID: 39328569

NOX2 Mediates NLRP3/ROS Facilitating Nasal Mucosal Epithelial Inflammation in Chronic Rhinosinusitis with Nasal Polyps

Overview
Journal Heliyon
Specialty Social Sciences
Date 2024 Sep 27
PMID 39328569
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous investigations have provided limited insight into the role of oxidative stress in nasal mucosa inflammation. The aim of this study was to investigate the mechanism of oxidative stress in the epithelial cells of chronic rhinosinusitis with nasal polyps CRSwNP utilizing single-cell RNA sequencing data.

Methods: Single-cell RNA sequencing data from HRA000772 were used to assess oxidative stress, inflammasome activation, and nicotinamide adenine dinucleotide phosphate oxidases (NOXs) expression in epithelial cells via integrative rank-based gene set enrichment analysis. The localization of reactive oxygen species (ROS) and NOX2 in nasal mucosa and cell models was visualized using fluorescent probes and immunohistochemistry, respectively. Functional studies on NOX2 involved siRNA and plasmid transfections , while Nucleotide-binding oligomerization domain-like receptor family pyrin domain containing 3 (NLRP3) inflammasome activity was examined using the inducer TMAO and the inhibitor MCC950.

Results: Single-cell RNA sequencing data suggested an increase of oxidative stress score and NLRP3 inflammasome score in CRSwNP epithelial cells. Vitro experiments demonstrated that lipopolysaccharide could induce ROS accumulation, NLRP3 inflammasome activation and epithelial alarmin expression. MCC950 inhibited the expression of epithelia alarmin . Elevated NOX2 in CRSwNP epithelial cells was associated with increased ROS, NLRP3 inflammasome activation, and epithelial alarmin expression. NOX2-targeted siRNA inhibited these effects . Moreover, TMAO reversed the downregulation of epithelial alarmins without impacting ROS levels.

Conclusion: This study highlights the crucial role of NOX2 as a key regulator of ROS accumulation and NLRP3 inflammasome activation in CRSwNP, underscoring its potential as a valuable therapeutic target for CRSwNP.

References
1.
Schleimer R . Immunopathogenesis of Chronic Rhinosinusitis and Nasal Polyposis. Annu Rev Pathol. 2016; 12:331-357. PMC: 5514544. DOI: 10.1146/annurev-pathol-052016-100401. View

2.
Wu P, Chiu C, Huang Y, Fan Y, Lee T, Chang P . Tissue eosinophilia and computed tomography features in paediatric chronic rhinosinusitis with nasal polyps requiring revision surgery. Rhinology. 2023; 61(3):348-357. DOI: 10.4193/Rhin22.435. View

3.
Ramkumar S, Marks L, Lal D, Marino M . Outcomes of limited versus extensive surgery for chronic rhinosinusitis: A systematic review and meta-analysis. Int Forum Allergy Rhinol. 2023; 13(11):2096-2100. DOI: 10.1002/alr.23178. View

4.
Huang W, Huang T, Yeh K, Chen Y, Shen S, Liou C . Ginsenoside Rg3 ameliorates allergic airway inflammation and oxidative stress in mice. J Ginseng Res. 2021; 45(6):654-664. PMC: 8569325. DOI: 10.1016/j.jgr.2021.03.002. View

5.
Xie S, Zhang C, Xie Z, Zhang J, Zhang H, Jiang W . Serum metabolomics identifies uric acid as a possible novel biomarker for predicting recurrence of chronic rhinosinusitis with nasal polyps. Rhinology. 2023; 61(6):541-551. DOI: 10.4193/Rhin23.236. View